| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 143 |
| 1 | INFLIXIMAB | 131 |
| 2 | METHOTREXATE SODIUM | 118 |
| 3 | PREDNISONE | 118 |
| 4 | ASPIRIN | 106 |
| 5 | METHOTREXATE | 105 |
| 6 | ASPIRIN 325 MG | 103 |
| 7 | ASPIRIN 81 MG | 103 |
| 8 | FLUOROURACIL | 102 |
| 9 | FLUOROURACIL CREAM, 0.5% | 102 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 1 | CHLOROXYLENOL 0.3% | 1 | 0.0345 |
| 2 | BEXAGLIFLOZIN | 1 | 0.0323 |
| 3 | TRIMIPRAMINE MALEATE | 4 | 0.0101 |
| 4 | HALCINONIDE | 1 | 0.0052 |
| 5 | FLUTAMIDE | 5 | 0.0051 |
| 6 | TOREMIFENE CITRATE | 2 | 0.0046 |
| 7 | CLINDAMYCIN PHOSPHATE | 23 | 0.0042 |
| 8 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 9 | BETAXOLOL HYDROCHLORIDE | 2 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 288 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 270 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 217 |
| 3 | Platinum-based Drug [EPC] | 217 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 169 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 141 |
| 6 | Kinase Inhibitor [EPC] | 133 |
| 7 | Microtubule Inhibitor [EPC] | 120 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 108 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 100 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 25 | 0.0363 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | Provitamin D2 Compound [EPC] | 62 | 0.0021 |
| 3 | Actinomycin [EPC] | 3 | 0.0014 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 11 | 0.0013 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 7 | 0.0011 |
| 6 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 7 | Anti-coagulant [EPC] | 4 | 0.0011 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |